Literature DB >> 17503117

Coping with neuroimmunological diseases.

Thomas Klauer1, Wolfgang Schneider, Uwe K Zettl.   

Abstract

Although there is little doubt about a considerable need for psychosocial support in patients with severe neuroimmunological diseases, the theoretical elaboration of stressful illness consequences as well as the development of standardised intervention programs are still in their beginnings. In the present paper, models of coping with chronic illness are characterised as a suitable framework. After a short overview of psychological dimensions of physical illness, concepts from the coping literature that seem to meet these demands are briefly introduced. Furthermore, recent results of coping research especially in multiple sclerosis (MS) are outlined in an overview which also includes findings from evaluation studies. Moreover, aims and techniques, which constitute necessary elements of coping skills training for patients with neuroimmunological disease, are described. Questions of suitability of coping interventions for subgroups of patients with multiple sclerosis are finally discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17503117     DOI: 10.1007/s00415-007-2026-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Adjustment to multiple sclerosis: application of a stress and coping model.

Authors:  K I Pakenham
Journal:  Health Psychol       Date:  1999-07       Impact factor: 4.267

2.  Teaching coping skills enhances quality of life more than peer support: results of a randomized trial with multiple sclerosis patients.

Authors:  C E Schwartz
Journal:  Health Psychol       Date:  1999-05       Impact factor: 4.267

3.  Coping with general and disease-related stressors by patients with multiple sclerosis: relationships to psychological distress.

Authors:  V M Jean; W W Beatty; R H Paul; L Mullins
Journal:  Mult Scler       Date:  1997-06       Impact factor: 6.312

4.  [Coping with illness in myasthenia gravis in comparison with other chronic neuromuscular diseases].

Authors:  H Glücker; W A Nix; H Willenberg; S O Hoffmann
Journal:  Nervenarzt       Date:  1998-10       Impact factor: 1.214

5.  Increased depression in multiple sclerosis patients. A meta-analysis.

Authors:  D S Schubert; R H Foliart
Journal:  Psychosomatics       Date:  1993 Mar-Apr       Impact factor: 2.386

6.  Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.

Authors:  David C Mohr; Donald E Goodkin; Sarah Nelson; Darcy Cox; Michael Weiner
Journal:  Psychosom Med       Date:  2002 Sep-Oct       Impact factor: 4.312

7.  A sequential criterion analysis for assessing coping with chronic illness.

Authors:  D C Turk; H J Sobel; M J Follick; H D Youkilis
Journal:  J Human Stress       Date:  1980

8.  Coping and psychological adjustment among people with multiple sclerosis.

Authors:  Marita P McCabe; Suzanne McKern; Elizabeth McDonald
Journal:  J Psychosom Res       Date:  2004-03       Impact factor: 3.006

  8 in total
  4 in total

1.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

2.  Unmet needs of patients feeling severely affected by multiple sclerosis in Germany: a qualitative study.

Authors:  Maren Galushko; Heidrun Golla; Julia Strupp; Ute Karbach; Claudia Kaiser; Nicole Ernstmann; Holger Pfaff; Christoph Ostgathe; Raymond Voltz
Journal:  J Palliat Med       Date:  2014-02-14       Impact factor: 2.947

3.  Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.

Authors:  Sverker Johansson; Kristina Gottberg; Marie Kierkegaard; Charlotte Ytterberg
Journal:  BMC Neurol       Date:  2016-03-05       Impact factor: 2.474

4.  Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.

Authors:  Paulus S Rommer; Nicolaus König; Annett Sühnel; Uwe K Zettl
Journal:  CNS Neurosci Ther       Date:  2018-04-10       Impact factor: 5.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.